期刊文献+

拉米夫定停药后出现肝衰竭患者hbv基因型及基因变异 被引量:4

hbv genotypes and gene mutations in patients with liver failure after withdrawal of lamivudine
原文传递
导出
摘要 目的 研究拉米夫定治疗慢性乙型肝炎(chb)停药后复发及出现肝衰竭患者的hbv基因型和基因变异的特点.方法 将拉米夫定治疗chb停药后复发的患者按临床诊断分为肝衰竭组(12例)和慢性肝炎组(12例),采集患者临床资料和血清,从血清中提取hbv dna,用pcr扩增,克隆后进行hbv测序和基因分型.结果 肝衰竭组中有6例成功完成测序,其中b、c基因型各3例;慢性肝炎组中有9例成功完成测序,其中b、c基因型分别是2例和7例.hbv序列与野生株比较,均出现能够引起包括编码s、p、c、x蛋白氨基酸改变的多个位点的变异.在同一基因型中,各病毒株之间的变异具有较高的一致性,p区出现变异的机会最多.拉米夫定停药后出现肝衰竭患者的hbv序列中可检测到位于bcp区、p区内高度保守序列的变异.结论 拉米夫定停药后出现肝衰竭的患者hbv基因b型和基因c型各占一半,出现位于bcp区和p区内高度保守序列变异的患者拉米夫定停药后更易出现肝衰竭.abstract:objective to investigate hbv genotypes and gene mutations in chrenic hepatitis b (chb) patients with liver failure after lamivudine withdrawal. methods twenty four patients with relapsing chb after lamivudine withdrawal were divided into liver failure group ( n = 12 ) and chronic hepatitis group ( n = 12 ). hbv dna from these patients was amplified by pcr. the pcr products were cloned into pgem-t vector and hbv dna sequences were analyzed. results in liver failure group, there were 6 sequences detected, in which 3 were of genotype b and 3 were of genotype c. in chronic hepatitis group, there were 9 sequences detected, in which 2 were of genotype b and 7 were of genotype c. compared with the wild type hbv sequences, there were multiples mutations in s, p, c, x regions. gene mutations in high conservative sequences of bcp and p regions were detected in liver failure patients after lamivudine withdrawal. conclusions in hbv patients with liver failure after lamivudine withdrawal, half of them were of genotype b and the others were of genotype c. some mutations in high conservative sequences of bcp and p regions may be related to the liver failure in these patients.
出处 《中华临床感染病杂志》 CAS 2008年第2期-,共4页 Chinese Journal of Clinical Infectious Diseases
  • 相关文献

参考文献16

  • 1Yotsuyanagi H;Hino K;Tomita E.Precore and core promoter mutations,hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B[J],2002(03).
  • 2李嘉,朱理珉,梁树人,李顺天,徐健.乙型肝炎病毒核心区基因变异与细胞免疫[J].中华肝脏病杂志,2003,11(9):533-535. 被引量:7
  • 3Lim SG;Wai CT;Rajnakova A.Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B[J],2002(04).
  • 4Warner N;Locamini S;Kuiper M.The rtLSOi substitution in the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro[J],2007(07).
  • 5Pan XP;Li LJ;Du WB.Differences of YMDD mutational patterns,precore/core promoter mutations,scram HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C[J],2007(11).
  • 6Yuen MF;Tanaka Y;Lai CL.Hepatitis B genotypes in chronic hepatitis B and lamivudins therapy[J],2003(06).
  • 7Lindh M;Hannoun C;Dhillon AP.Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers[J],1999(04).
  • 8黄晶,高志良.乙型肝炎病毒基因型及其临床意义的研究[J].世界华人消化杂志,2002,10(11):1362-1364. 被引量:29
  • 9中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14006
  • 10Bottecchia M;Ikuta N;Niel C.Lamivudine resistance and other mutations in the polymerase and surface antigen genes of hepatitis B vires associated with a fatal hepatic failure case[J],2008(01).

二级参考文献19

  • 1张晓红,lin bing-liang,杨绍基,gao zhi-liang.拉米夫定停药后出现肝衰竭患者hbv基因型及基因变异[J].中华临床感染病杂志,2008,1(2). 被引量:4
  • 2许正锯,杨红,陈先礼,沈建坤,张启华,王崇国.重型肝炎患者乙型肝炎病毒基因型及其进化树分析[J].中华肝脏病杂志,2006,14(10):785-787. 被引量:6
  • 3左兴(综述,谢奇峰(审校),杨林(审校).HBV基因分型的研究进展[J].国际内科学杂志,2007,34(3):180-183. 被引量:10
  • 4Ferrari C, Penna A, Bertoletti A, et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol, 1990, 145: 3442-3449.
  • 5Milich DR, McLachlan A, Moriarty A, et al. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg. J Immunol, 1987, 139: 1223-1231.
  • 6Prezzi C, Casciaro MA, Francavilla V, et al. Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur J Immunol,2001, 31: 894-906.
  • 7Tomaras GD, Greenberg ML. CD8^+ T cell mediated noncytolytic inhibition of human immunodeficiency virus type I. Front Biosci,2001, 6: 575-598.
  • 8Webster G J, Reignat S, Maini MK, et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.Hepatology, 2000, 32: 1117-1124.
  • 9Malni MK, Boni C, Lee CK, et al. The role of virus-specific CD8(+)cells in liver damage and viral control during persistent hepatitis B virus infection, J Exp Med, 2000, 191: 1269-1280.
  • 10骆抗先.乙型肝炎基础和临床[M].北京:人民卫生出版社,2001.327.

共引文献14045

同被引文献35

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部